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Abstract We report on a 10-year-old patient with develop-
mental delay, craniofacial dysmorphism, digital and genital
abnormalities. In addition, muscular hypotonia, strabism, and
splenomegaly were observed; inguinal and umbilical hernias
were surgically corrected. Mucopolysaccharidoses and CDG
syndromes could not be found. Chromosome analysis
revealed a normal male karyotype (46,XY). A more detailed
investigation of the patient’s genomic DNA by microarray-
based comparative genomic hybridization (array CGH)
detected an interstitial 3.7 Mb deletion ranging from
15q24.1 to 15q24.3 which was shown to be de novo.
Interstitial deletions involving 15q24 are rare. Sharp et al.
(Hum Mol Genet 16:567–572, 2007) recently characterized a
recurrent 15q24 microdeletion syndrome with breakpoints in
regions of segmental duplications. The de novo micro-
deletion described here colocalizes with the minimal deletion
region of the 15q24 microdeletion syndrome. The distinct
clinical phenotype associated with this novel microdeletion
syndrome is similar to the phenotype of our patient with
respect to specific facial features, developmental delay,
microcephaly, digital abnormalities, and genital abnormalities
in males. We present a genotype–phenotype correlation and
comparison with patients from the literature.
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Abbreviations
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CNV copy number variation
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Introduction
Microdeletion syndromes are recurrent deletions associated
with a distinct phenotype. These microdeletions often occur
between low copy repeats and are commonly due to
liability to unequal crossing over. It was recently shown
that the well known classical microdeletion syndromes such
as DiGeorge and Williams syndromes account for about 5%
of all patients with mental retardation [18]. Besides the
detection of known microdeletion syndromes, microarray-
based comparative genomic hybridization (array CGH) or
molecular karyotyping recently led to the discovery of
novel recurrent microdeletion syndromes such as 17q21.31
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Berlin, Germanyand 15q24 [12, 20, 21]. To date 14 patients have been
reported who have interstitial deletions at 15q22-q24 [1, 3, 4,
7, 13, 20, 22], but only three of them are restricted to
chromosomal band 15q24 [4, 20]. So far, only a few of these
cases have been molecularly characterized in order to
determine the size of the affected regions. Despite consider-
able phenotypic variability, patients with 15q24 microdeletion
syndrome share common features including global develop-
mental delay, hypotonia, and genital abnormalities in males.
In order to further delineate the 15q24 genotype–phenotype
correlation, a novel patient with 15q24 microdeletion detected
by array CGH is presented.
Clinical report
We present a boy who is the second child of healthy
Caucasian parents. The mother underwent spine CT scan in
the 8th week of gestation. The further course of pregnancy
was uneventful and delivery by Caesarean section was at
38 weeks of gestation after preterm hydrorrhoea. Physical
examination at the age of 10 years revealed a height of
132.5 cm (P50), weight of 35.7 kg (P50–75) and head
circumference of 53.5 cm (P75). Our patient presented with
developmental retardation, craniofacial dysmorphism, trun-
cal obesity, and micropenis (Fig. 1a,b). In addition, general
muscular hypotonia and splenomegaly were observed. He
showed lumbar hyperlordosis, mild genua valga, and joint
hypermobility. At the age of 6 months coordination
disturbances were noted. Unaided walking was possible at
18 months.
Speech development was retarded and a mild mental
retardation (IQ ∼65) was observed. Nasal speech and a
hoarse voice were apparent. Prominent veins were evident
on the trunk. Skin laxity was noted especially in the face
and hands. We observed a convergent squint, astigmatism,
and amblyopia. Inguinal and umbilical hernias as well as
unilateral retentio testis inguinalis were surgically corrected
at age 4 years. Patient’s hands show mild brachydactyly,
clinodactyly of fourth finger (left hand), and broad thumbs
(Fig. 1c,d). Radiological investigations including cranial
CT were normal except for hand radiographs disclosing
hypoplasia of distal phalanges, short mesophalanges, delay
of carpal ossification (corresponding to the state of a 3 year
old child), irregular epiphyses of the second and fifth
mesophalanges and of the distal phalanx of the thumb
(Fig. 1e).
Echocardiography as well as renal ultrasound and neuro-
physiological investigations (i.e. nerve velocity, EEG, ECG)
did not reveal any pathological findings. In repeated
metabolic screenings triglycerides and the LDL/HDL quotient
were always elevated. He was only able to walk up to 100 m.
Clinically, a metabolic defect was suspected. However,
examinations concerning mucopolysaccharidoses and CDG
syndrome disclosed no abnormalities. All serum parameters
including growth related factors (IGF1, IGFBP3) were
normal. FSH (18 U/l) and testosterone (1.4 ng/ml) values
were normal for the patient’sa g e .T h i ss t u d yw a sa p p r o v e d
by the ethics committee of the Charité, Universitätsmedizin
Berlin, and all individuals gave their informed consent prior
to their inclusion in the study.
Fig. 1 a, b Patient at the age of
10 years. Note truncal obesity,
widely spaced, inverted nipples,
as well as coarse face with high
forehead, broad medial eye-
brows, periorbital fullness, slight
antimongoloid slant, deep set
eyes, hypoplastic nostrils, long
philtrum and full cheeks. c, d
Hands show mild brachydactyly,
clinodactyly of fourth finger
(left hand) and broad thumbs.
e Note hypoplasia of the distal
phalanges, short mesophalanges,
delayed carpal ossification
(corresponding to the state of a
3 year old child), irregular
epiphyses of the second and
fifth mesophalanges and of the
distal phalanx of the thumb
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Cytogenetics
Karyotyping of GTG-banded chromosomes from lymphocytes
at 450 bands resolution was performed according to standard
procedures.
Fluorescence in situ hybridization (FISH)
BAC clones RP11–414J4 (genomic position 72.7–72.9 Mb)
and RP11–94P14 (genomic position 75.2–75.3 Mb) were
obtained from the RZPD (Deutsches Ressourcenzentrum
für Genomforschung, Berlin, Germany). Genomic positions
are according to the Ensembl Genome Browser v44, April
2007. BAC DNA was fluorescently labelled using nick
translation and hybridized to metaphase spreads of the
patient’s and parents’ lymphocytes using standard proce-
dures. BAC clones RP11–414J4 and RP11–94P14 were
labelled with spectrum orange. Centromere probe, Cep15
(D15Z1; Vysis, Downers Grove, IL), labelled with spectrum
green was used as control probe. Chromosomes were
counterstained with DAPI (4′,6-diamidino-2-phenylindole).
Hybridization of the commercial probes for SNRPN (Prader-
Willi/Angelman region) and TUPLE1 (DiGeorge/VCFS
region) were performed on metaphase spreads of the patient
as recommended by the manufacturer (Vysis, Downers
Grove, IL).
Microarray-based comparative genomic hybridization
(array CGH)
Array CGH was carried out using a submegabase whole
human genome tiling path BAC array consisting of the human
32k Re-Array set (http://bacpac.chori.org/pHumanMinSet.
htm)[ 14, 18], the 1Mb Sanger Clone set (Wellcome Trust
Sanger Institute) [6], and a set of 390 subtelomeric clones
(generated in the course of the EU initiative COSTB19:
Molecular cytogenetics of solid tumours). Detailed protocols
are available at the following webpage: http://www.molgen.
mpg.de/~abt_rop/molecular_cytogenetics/Protocols.html.
Array CGH was performed as described previously [11]a n d
33028 BACs were included in the analysis. The log2ratio of
test to reference was calculated and plotted according to
chromosomal position of the clones. Copy number gains and
losses were determined by a conservative threshold of 0.3 and
−0.3, respectively. Profile deviations consisting of three or
more neighbouring BAC clones were considered as genomic
aberrations and were further evaluated by FISH, unless they
coincided with a published variant as listed in the Database of
Genomic Variants (http://projects.tcag.ca/variation/;v e r s i o n
Oct. 11, 2006). For visualizing the content of low copy
repeats in the ratio plots (Fig. 2a,b), each BAC clone was
classified into one out of seven categories and colour-coded as
described previously [2].
Results
Standard karyotyping of G-banded chromosomes did not
reveal any chromosomal abnormalities. According to the
FISH analyses there was no evidence for a deletion of the
Prader-Willi syndrome region or a microdeletion 22q11.2.
Therefore, we performed array CGH analysis with the
patient’s genomic DNA using a submegabase resolution
whole genome tiling path array to detect microdeletions or
duplications. A submicroscopic interstitial deletion on
chromosome 15q24.1-q24.3 represented by 33 BAC clones
was detected (Fig. 2). The size of the deletion is
approximately 3.7 Mb extending from 72.2 Mb to
75.9 Mb (Ensembl release 43; Feb. 2007). According to
the array CGH data the two breakpoints are located
between RP11–247C02 and RP11–672A20 (proximal
breakpoint) and RP11–758J16 and RP11–745I11 (distal
Fig. 2 a Array CGH profile of chromosome 15 visualized using
CGHPRO software. Each spot represents one BAC clone on the array.
The red and green lines indicate the log2ratio thresholds −0.3 (loss)
and 0.3 (gain), respectively. Note: the aberration close to the
centromere on 15q11.2 constitutes a known CNV indicated by the
turquoise colour of the spots. b Detailed view of the interstitial
deletion on chromosome 15q24. The microdeletion is flanked by low-
copy repeats indicated by the turquoise colour of the spots. Horizontal
bars represent DNA copy number variants as listed in the Database of
Genomic Variants (Dec. 2005)
Eur J Pediatr (2008) 167:903–908 905breakpoint). Both breakpoints were found to be enriched
for low copy repeats, which, according to the Segmental
Duplication Database (http://humanparalogy.gs.washington.
edu/), share a 49.9 kb segment with 95% sequence
similarity (no .9417), and the proximal breakpoint coincid-
ed with published DNA copy number variants. Given this
high sequence similarity the deletion most likely emerged
through nonallelic homologous recombination (NAHR) of
the two breakpoint flanking low copy repeats (LCRs), a
mechanism associated with genomic rearrangements [16].
The deleted region comprises 39 annotated genes (based on
v39, June 2006, Ensembl genome browser; (http://www.
ensembl.org). In addition, a deletion on 15q11.2 was
observed which represents a CNV listed in the Database
of Genomic Variants and was therefore considered as a
benign variant without pathological relevance.
For verification of array CGH data by FISH we used a
set of BAC clones mapping to 15q24. As expected from the
array data (log2ratio < −0.3) only one signal on the
patient’s metaphases was detected for BAC clones RP11–
414J4 and RP11–94P14 (data not shown). FISH on
metaphase chromosomes of the patient’s parents and his
brother detected two signals on chromosome 15 for all
probes investigated and karyotypes were normal (data not
shown). Thus, the aberration observed in our patient
occurred de novo.
Discussion
Recently, Sharp et al. described a recurrent microdeletion of
15q24 in four cases ranging in size from 1.7–3.9 Mb
characterised by molecular cytogenetic techniques [21].
The minimal deletion region was delineated to be 1.7 Mb in
size (72.15–73.85 Mb). The patient presented here consti-
tutes an interstitial microdeletion at 15q24 which shares
common proximal (BP1) and distal breakpoints (BP3) with
cases IMR349 and C45/06 of the publication by Sharp et al.
[21]( F i g .3). Since all deletions occurred in the maternal
lineage the possibility of an underlying imprinting effect was
pointed out [21]. The parental origin of the deletion was not
analysed in our patient. A clinical comparison of our patient
to these patients from the literature is shown in Table 1.T h e
phenotype between patients with microdeletion 15q24 is
variable; however, our patient shares all of the major features
described for 15q24 microdeletion syndrome by Sharp et al.
[21], i.e. unusual facial features (high frontal hairline, broad
medial eyebrows, downslanted palpebral fissures, and long
philtrum), developmental delay, digital abnormalities, genital
abnormalities, and loose connective tissue (manifestation:
joint laxity, inguinal hernia). However, our patient does not
present with microcephaly (3/4), prenatal and postnatal
growth deficiency (3/4), hearing problems (2/4), or bowel
atresia (2/4).
Among the deleted genes are several coding for enzymes,
e.g. mannose phosphate isomerase (MPI), alpha-mannosidase
2C1 (MAN2C1), and alpha-subunit of electron transfer
flavoprotein (ETFA), as well as the cytochrome P450 side-
chain cleavage enzyme (P450scc) which catalyzes the first
step in steroidogenesis. Several of these enzymes are involved
in the synthesis, export, and degradation of glycoproteins.
Mutations in the MPI gene (MIM 154550) cause congenital
disorder of glycosylation type Ib (CDG Ib) [9, 19]. CDG Ib is
an autosomal recessive disorder showing abnormalities in the
glycosylation of glycoproteins. Therefore, the haploinsuffi-
ciency is asymptomatic. MAN2C1 (MIM 154580) is involved
in the degradation of oligomannosides derived from dolichol
intermediates, the degradation of newly synthesized glyco-
Fig. 3 Schematic representation
of 15q24 region. The three
recurrent breakpoints as delin-
eated by Sharp et al. [21] as well
as the deletion sizes of the
presented case and published
cases are indicated. The critical
region is located between the
recurrent breakpoints BP1 and
BP2
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are formed in the cytosol [23]. Secretory carrier membrane
proteins (SCAMP2, SCAMP5) are a family of post-Golgi and
Golgi membrane proteins which have been implicated in
vesicular trafficking. SCAMPs interact with NHE7 (Na
+/H
+
exchanger) and participate in the shuttling and retrieval of
NHE7 from peripheral recycling endosomes to the trans-Golgi
network [15]. Mucopolysaccharidoses and CDG syndrome
were ruled out biochemically. However, the second allele was
not analysed for point mutations. Thus, we cannot exclude
uncovering of a recessive condition which could result in a
homozygous loss of alleles which leads to deficiency of one
of the other enzymes in this region.
The cholesterol side chain cleavage enzyme P450scc is
responsible for the conversion of cholesterol to pregnenolone
in mitochondria [17]. This is the first and rate-limiting step in
steroidogenesis [17]. So far, only one patient with a
heterozygous mutation in P450scc has been described [24].
This patient had a late-onset form of congenital lipoid
adrenal hyperplasia without the characteristic enlargement of
the adrenals. A complete absence of P450scc activity causes
congenital adrenal insufficiency, complete 46,XY sex rever-
sal, and severe adrenal failure [8, 10]. Congenital adrenal
hyperplasia is a severe disorder with an impairment of
adrenal and gonadal steroid synthesis. Although, we did not
observe such a severe phenotype, and current steroid levels
Table 1 Phenotypic comparison of patients with interstitial 15q24 deletion
Present case Cushman et
al. [4]
Patient 1
Cushman
et al. [4]
Patient 2
Sharp et al. [20]
IMR349
Sharp et al. [21]
IMR 371
Sharp et al.
[21] ID204
Sharp et al.
[21] C45/06
Male, 10 years Male,
23 months
Female,
11 years
Male, 14 years Male, 15 years Male, 33 years Male,
14 years
Short stature −− − + − ++
Hypotonia + + + ND ND ND +
Developmental
delay/mental
retardation
+ + + + + Mild +
Microcephaly −− − + − ++
Strabismus + + ND −− ++
Hypertelorism −− ND + + + +
Micrognathia − +N D −− − −
Palate anomaly −− ++ −− −
Full lower lip − ++ + +
Ear anomaly − +N D + − ++
Epicanthal folds − +N D −− + −
High frontal
hair line
+N D + + + +
Broad medial
eyebrows
+N D + + + +
Long/smooth
philtrum
+N D + + + +
Downslanted
palpebral
fissures
+N D N D + − ++
Hernia Inguinal and
umbilical
− ND − Diaphragmatic,
inguinal and
hiatal
−−
Genital
anomaly
Micropenis Micropenis,
small
scrotum
ND − Coronal
hypospadias with
phimosis
Mild
hypospadias
Hypospadias
Musculoskeletal
anomaly
Joint laxity,
clinodactyly of
fourth finger
(left hand),
Brachymeso-
phalangy V
Clinodactyly
of fifth
fingers,
distal
tapering of
fingers
ND Joint laxity, long
slender fingers,
proximally
implanted
thumbs, sandal
gap, scoliosis
Joint laxity,
hypoplastic right
thumb,
contractures of
fingers, pes cavus,
camptodactyly of
toes
Joint laxity,
small hands,
distal brachy-
dactyly, mild
cutaneous
syndactyly
Proximal
implanted
thumbs,
scoliosis
+ feature present, − feature absent, ND feature not described
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might contribute to the genital abnormalities in our patient
and other affected male patients (microphallus with small
scrotum, undescended testes, hypospadias) with deletions
spanning the P450scc locus on 15q24.1 [4, 20].
In summary, the patient presented here constitutes an
interstitial microdeletion at 15q24 and represents another case
of the recently described 15q24 microdeletion syndrome.
This is another example of the impact of array CGH as a
diagnostic tool in clinical medicine [5].
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